---
$id: https://graph.org.ai/products/commodity/51263125
$type: Product
source: UNSPSC
code: "51263125"
title: "Levobunolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levobunolol

**UNSPSC Code**: 51263125
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent and anti-glaucoma agent with the molecular formula C17H25NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G6317AOI7K, chemically known as 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxy)propoxy-1(2h)-naphthalenone but generally known as levobunolol, which bears US NIH Compound Identifier 3914. European Medicines Agency schedules Levobunolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08463MIG. The term LEVOBUNOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules levobunolol in its Anatomical Therapeutic Chemical (ATC) Classification. LEVOBUNOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule levobunolol under HS 29221980 and SITC 51461. As of Q4 2014, LEVOBUNOLOL remains the US FDA Preferred Term for this commodity. Levobunolol bears US NLM identifiers UMLS ID C0006388 and NCI Concept Code C62043. SMILES: O(C1C2CCCC(=O)C2CCC1)CC(O)CNC(C)(C)C.

